生物医药系列产品
数据
资源
版本对比
免费注册
预约演示
免费注册
A Robust
Neuromyelitis Optica Spectrum Disorder
Pipeline Domain Witnesses Several Novel and Promising Therapies in Different Stages of Clinical Development Expected to Enter the Market by the Next Dec
2021-08-05
·
GlobeNewswire
Los Angeles, USA, Aug. 04, 2021 (GLOBE NEWSWIRE) -- A Robust
Neuromyelitis Optica Spectrum Disorder
Pipeline Domain Witnesses Several Novel and Promising Therapies in Different Stages of Clinical Development Expected to Enter the Market by the Next Decade DelveInsight’s analysis demonstrates a robust
Neuromyelitis Optica Spectrum Disorder
Pipeline with 15+ active players in the domain working on 15+ pipeline therapies. DelveInsight’s ‘
Neuromyelitis Optica Spectrum Disorder
Pipeline Insights’ report presents an exhaustive coverage of the available therapies,
Neuromyelitis Optica Spectrum Disorder
emerging therapies in different phases of clinical development, key companies working in the
Neuromyelitis Optica Spectrum Disorder
pipeline domain, and future potential of the space. Some of the notable pointers extracted from the
Neuromyelitis Optica Spectrum Disorder
Pipeline report: Request for Sample to know more about the therapies expected to make grab the maximum patient pool @
Neuromyelitis Optica Spectrum Disorder
Emerging Therapies and Forecast The
Neuromyelitis Optica Spectrum Disorder
Pipeline reports lays down a comprehensive structure of the ongoing clinical trials, partnerships taking place in the domain, recent happenings in space, and growth prospects across the
Neuromyelitis Optica Spectrum Disorder
domain.
Neuromyelitis Optica Spectrum Disorder
Overview
Neuromyelitis Optica Spectrum Disorder (NMOSD)
, also referred to as
Devic disease
, is a chronic condition that causes
inflammation
of the optic nerve and spinal cord thereby affecting the brain and spinal cord. The condition is an
autoimmune disorder
, however, the exact pathophysiology and cause of the
autoimmunity
remain unclear. Discover more about the disease, treatments, and pipeline therapies @ NMOSD Pipeline Assessment
Neuromyelitis Optica Spectrum Disorder
Pipeline Drugs Request for Sample to know more @
Neuromyelitis Optica Spectrum Disorder
Pipeline Analysis,
Key Companies
, and Futuristic Trends
Neuromyelitis Optica Spectrum Disorder
Therapeutics Assessment The
Neuromyelitis Optica Spectrum Disorder
Pipeline report presents a holistic picture of the
Neuromyelitis Optica Spectrum Disorder
emerging novel therapies segmented by Stage, Product Type, Route of Administration, Molecule Type, Target, and Mechanism of Action. By Product Type By Stage By Molecule Type By Route of Administration By Mechanism of Action By Targets For rich insights into merging therapies and assessment, visit NMOSD Pipeline Emerging Novel Therapies Scope of the
Neuromyelitis Optica Spectrum Disorder
Pipeline Report Coverage: GlobalKey Players:
Alexion Pharmaceuticals
,
RemeGen
,
Reistone Biopharma
,
Chord Therapeutics
,
Nihon Pharmaceuticals
,
Harbour BioMed
,
Bio-Thera Solutions
,
Abide Therapeutics
,
Bionure
,
Boston Pharmaceuticals
, and
TG Therapeutics
among others.Key
Neuromyelitis Optica Spectrum Disorder
Pipeline Therapies:
Ravulizumab
,
Telitacicept
,
SHR1459
, CRD1,
HBM9161
, BAT4406F,
ABX-1431
,
BN201
,
ARN-6039
, and
Ublituximab
among others.Discover more about the scope of the report @
Neuromyelitis Optica Spectrum Disorder
Emerging Therapies, Treatments, and Ongoing Clinical Trials Table of Contents Learn more about the report offerings @
Neuromyelitis Optica Spectrum Disorder
Pipeline Therapies and Emerging Trends Audit the market before venturing with DelveInsight’s Due Diligence Services Related Reports
Neuromyelitis Optica Spectrum Disorder
MarketDelveInsight's "
Neuromyelitis Optica Spectrum Disorder
(
Neuromyelitis Optica Spectrum Disorder
) Market Insights, Epidemiology and Market Forecast-2028" report.
Pompe Disease
Market Insight Epidemiology And Market ForecastDelveInsight's "
Pompe Disease
Market Insights, Epidemiology and Market Forecast-2028" report. Spinal Muscular Atrophy Sma Market Insight Epidemiology And Market ForecastDelveInsight's '
Spinal Muscular Atrophy (SMA)
- Market Insights, Epidemiology and Market Forecast-2028' report.
Spinocerebellar Ataxias
Market Insights Epidemiology And Market ForecastDelveInsight's '
Spinocerebellar Ataxia (SCA)
- Market Insights, Epidemiology and Market Forecast-2028’ report.
Acute Ischemic Stroke
Market InsightsDelveInsight’s ‘
Acute Ischemic Stroke (AIS)
- Market Insights, Competitive Landscape and Market Forecast–2026’ report. Adult Intraventricular Hemorrhage MarketDelveInsight’s ‘Adult Intraventricular Haemorrhage Market Insights, Competitive Landscape and Market Forecast-2026’ report. Carotid Stenotic Scan Devices MarketDelveInsight’s ‘Carotid Stenotic Scan Devices Market Insights, Competitive Landscape and Market Forecast-2026’ report. Browse through our posts Dynamics Of
Schizophrenia
Market
Alzheimer’s Disease
Market LandscapeAdvancements in Neuromodulation in the
Neurological Disorders
MarketDeep Brain Stimulation Devices and Changing Market Landscape About DelveInsight DelveInsight is a leading Business Consultant and Market Research firm focused exclusively on life sciences. It supports
Pharma
companies by providing comprehensive end-to-end solutions to improve their performance. Get hassle-free access to all the healthcare and pharma market research reports through our subscription-based platform PharmDelve. For more insights, visit
Pharma
, Healthcare, and
Biotech
News
机构
Nihon Pharmaceutical Co., Ltd.
Alexion Pharmaceuticals, Inc.
荣昌生物制药(烟台)股份有限公司
[+11]
适应症
视神经脊髓炎
炎症
自身免疫性疾病
[+8]
靶点
-
药物
巴托利单抗
Ublituximab
Ravulizumab-CWVZ
[+5]
标准版
¥
16800
元/账号/年
新药情报库 | 省钱又好用!
立即使用
来和芽仔聊天吧
热门报告
特应性皮炎深度解析:药物开发、专利分析与风险评估
智慧芽生物医药
2024年7月全球首批及特殊审评药物报告
智慧芽生物医药
GPRC5D靶点专利调研报告
智慧芽生物医药
立即开始免费试用!
智慧芽新药情报库是智慧芽专为生命科学人士构建的基于AI的创新药情报平台,助您全方位提升您的研发与决策效率。
开始免费试用
立即开始数据试用!
智慧芽新药库数据也通过智慧芽数据服务平台,以API或者数据包形式对外开放,助您更加充分利用智慧芽新药情报信息。
试用数据服务